|
1
|
Amaranath BJ, Das N, Gupta I, Gupta R,
John B and Devi MP: Types of bone destruction and its severity in
chronic periodontitis patients with tobacco smoking habit using
periapical radiographs and transgingival probing: A cross-sectional
study. J Indian Soc Periodontol. 24:20–25. 2020.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Datey A, Thaha CSA, Patil SR, Gopalan J
and Chakravortty D: Shockwave therapy efficiently cures
multispecies chronic periodontitis in a humanized rat model. Front
Bioeng Biotechnol. 7(382)2019.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Techatanawat S, Surarit R, Chairatvit K,
Khovidhunkit W, Roytrakul S, Thanakun S, Kobayashi H, Khovidhunkit
SP and Izumi Y: Salivary and serum interleukin-17A and
interleukin-18 levels in patients with type 2 diabetes mellitus
with and without periodontitis. PLoS One.
15(e0228921)2020.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Bissett SM, Preshaw PM, Presseau J and
Rapley T: A qualitative study exploring strategies to improve the
inter-professional management of diabetes and periodontitis. Prim
Care Diabetes. 14:126–132. 2020.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Balmasova IP, Lomakin YA, Babaev EA,
Tsarev VN, Gabibov AG, Smirnov IV, Knorre VD, Ovchinnikova LA,
Gnuchev NV, Khurs EN, et al: ‘Shielding’ of cytokine induction by
the periodontal microbiome in patients with periodontitis
associated with type 2 diabetes mellitus. Acta Naturae. 11:79–87.
2019.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Zhao W, Zhang H, Yan J and Ma X: An
experimental study on the treatment of diabetes-induced cognitive
disorder mice model with exosomes deriving from mesenchymal stem
cells (MSCs). Pak J Pharm Sci. 32:1965–1970. 2019.PubMed/NCBI
|
|
7
|
Ulyanova O, Askarov M, Kozina L, Karibekov
T, Shaimardanova G, Zhakupova A, Danilova D and Serebrennikova D:
Autologous mesenchymal stem cell transplant in patients with type 1
diabetes mellitus. Exp Clin Transplant. 17 (Suppl 1):S236–S238.
2019.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Cho J, D'Antuono M, Glicksman M, Wang J
and Jonklaas J: A review of clinical trials: Mesenchymal stem cell
transplant therapy in type 1 and type 2 diabetes mellitus. Am J
Stem Cells. 7:82–93. 2018.PubMed/NCBI
|
|
9
|
Lin Y, Zhang F, Lian XF, Peng WQ and Yin
CY: Mesenchymal stem cell-derived exosomes improve diabetes
mellitus-induced myocardial injury and fibrosis via inhibition of
TGF-β1/Smad2 signaling pathway. Cell Mol Biol (Noisy-le-grand).
65:123–126. 2019.PubMed/NCBI
|
|
10
|
Fijany A, Sayadi LR, Khoshab N, Banyard
DA, Shaterian A, Alexander M, Lakey JRT, Paydar KZ, Evans GRD and
Widgerow AD: Mesenchymal stem cell dysfunction in diabetes. Mol
Biol Rep. 46:1459–1475. 2019.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Ouchi T and Nakagawa T: Mesenchymal stem
cell-based tissue regeneration therapies for periodontitis. Regen
Ther. 14:72–78. 2020.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Liu X, Wang Z, Song W, Sun W, Hong R,
Pothukuchi A and Xu Q: Systematically transplanted human
gingiva-derived mesenchymal stem cells regulate lipid metabolism
and inflammation in hyperlipidemic mice with periodontitis. Exp
Ther Med. 19:672–682. 2020.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Lu Z, Lei D, Jiang T, Yang L, Zheng L and
Zhao J: Nerve growth factor from Chinese cobra venom stimulates
chondrogenic differentiation of mesenchymal stem cells. Cell Death
Dis. 8(e2801)2017.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Pan Y, Jiao G, Yang J, Guo R, Li J and
Wang C: Insights into the therapeutic potential of heparinized
collagen scaffolds loading human umbilical cord mesenchymal stem
cells and nerve growth factor for the repair of recurrent laryngeal
nerve injury. Tissue Eng Regen Med. 14:317–326. 2017.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Cho YI, Choi JS, Jeong SY and Yoo HS:
Nerve growth factor (NGF)-conjugated electrospun nanostructures
with topographical cues for neuronal differentiation of mesenchymal
stem cells. Acta Biomater. 6:4725–4733. 2010.PubMed/NCBI View Article : Google Scholar
|
|
16
|
WenBo W, Fei Z, YiHeng D, Wei W, TingMang
Y, WenHao Z, QianRu L and HaiTao L: Human umbilical cord
mesenchymal stem cells overexpressing nerve growth factor
ameliorate diabetic cystopathy in rats. Neurochem Res.
42:3537–3547. 2017.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Rooney GE, Moran C, McMahon SS, Ritter T,
Maenz M, Flügel A, Dockery P, O'Brien T, Howard L, Windebank AJ and
Barry FP: Gene-modified mesenchymal stem cells express functionally
active nerve growth factor on an engineered poly lactic glycolic
acid (PLGA) substrate. Tissue Eng Part A. 14:681–690.
2008.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Chen W, Wu Y, Li L, Yang M, Shen L, Liu G,
Tan J, Zeng W and Zhu C: Adenosine accelerates the healing of
diabetic ischemic ulcers by improving autophagy of endothelial
progenitor cells grown on a biomaterial. Sci Rep.
5(11594)2015.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Waterman RS, Tomchuck SL, Henkle SL and
Betancourt AM: A new mesenchymal stem cell (MSC) paradigm:
Polarization into a pro-inflammatory MSC1 or an immunosuppressive
MSC2 phenotype. PLoS One. 5(e10088)2010.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Svobodova E, Krulova M, Zajicova A,
Pokorna K, Prochazkova J, Trosan P and Holan V: The role of mouse
mesenchymal stem cells in differentiation of naive T-cells into
anti-inflammatory regulatory T-cell or proinflammatory helper
T-cell 17 population. Stem Cells Dev. 21:901–910. 2012.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Né YGS, Martins BV, Castro MML, Alvarenga
MOP, Fagundes NCF, Magno MB, Maia LC and Lima RR: Is nutritional
intervention an improvement factor in the management of
periodontitis? A systematic review. Clin Nutr. 39:2639–2646.
2020.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Zare Javid A, Bazyar H, Gholinezhad H,
Rahimlou M, Rashidi H, Salehi P and Haghighi-Zadeh MH: The effects
of ginger supplementation on inflammatory, antioxidant, and
periodontal parameters in type 2 diabetes mellitus patients with
chronic periodontitis under non-surgical periodontal therapy. A
double-blind, placebo-controlled trial. Diabetes Metab Syndr Obes.
12:1751–1761. 2019.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Zhu C, Zhao Y, Wu X, Qiang C, Liu J, Shi
J, Gou J, Pei D and Li A: The therapeutic role of baicalein in
combating experimental periodontitis with diabetes via Nrf2
antioxidant signaling pathway. J Periodontal Res. 55:381–391.
2020.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Hernández-Monjaraz B, Santiago-Osorio E,
Monroy-Garcia A, Ledesma-Martinez E and Mendoza-Núñez VM:
Mesenchymal stem cells of dental origin for inducing tissue
regeneration in periodontitis: A mini-review. Int J Mol Sci.
19(944)2018.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Hoveizi E and Tavakol S: Therapeutic
potential of human mesenchymal stem cells derived beta cell
precursors on a nanofibrous scaffold: An approach to treat diabetes
mellitus. J Cell Physiol. 234:10196–10204. 2019.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Shen Y, Feng Z, Lin C, Hou X, Wang X, Wang
J, Yu Y, Wang L and Sun X: An oligodeoxynucleotide that induces
differentiation of bone marrow mesenchymal stem cells to
osteoblasts in vitro and reduces alveolar bone loss in rats with
periodontitis. Int J Mol Sci. 13:2877–2892. 2012.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Zhu SX, Huang SY, Su YM and Cai P: Growth
and expression of rat bone marrow mesenchymal stem cells modified
by nerve growth factor in diabetic rat bladders. Mol Med Rep.
7:1791–1799. 2013.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Tomellini E, Touil Y, Lagadec C, Julien S,
Ostyn P, Ziental-Gelus N, Meignan S, Lengrand J, Adriaenssens E,
Polakowska R and Le Bourhis X: Nerve growth factor and proNGF
simultaneously promote symmetric self-renewal, quiescence, and
epithelial to mesenchymal transition to enlarge the breast cancer
stem cell compartment. Stem Cells. 33:342–353. 2015.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Valdovinos-Flores C, Limón-Pacheco JH,
León-Rodríguez R, Petrosyan P, Garza-Lombó C and Gonsebatt ME:
Systemic L-buthionine-S-R-sulfoximine treatment increases plasma
NGF and upregulates L-cys/L-cys2 transporter and γ-glutamylcysteine
ligase mRNAs through the NGF/TrkA/Akt/Nrf2 pathway in the striatum.
Front Cell Neurosci. 13(325)2019.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Jiang Y and Tuan RS: Role of NGF-TrkA
signaling in calcification of articular chondrocytes. FASEB J.
33:10231–10239. 2019.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Zhang J, Yi QT, Gong M, Zhang YQ, Liu D
and Zhu RJ: Upregulation of TRPV1 in spinal dorsal root ganglion by
activating NGF-TrkA pathway contributes to pelvic organ
cross-sensitisation in rats with experimental autoimmune
prostatitis. Andrologia. 51(e13302)2019.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Lin C, Ren Z, Yang X, Yang R, Chen Y, Liu
Z, Dai Z, Zhang Y, He Y, Zhang C, et al: Nerve growth factor
(NGF)-TrkA axis in head and neck squamous cell carcinoma triggers
EMT and confers resistance to the EGFR inhibitor erlotinib. Cancer
Lett. 472:81–96. 2020.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Sanchez-Rodriguez A, Arias-Alvarez M,
Timón P, Bautista JM, Rebollar PG, Lorenzo PL and Garcia-Garcia RM:
Characterization of β-Nerve Growth Factor-TrkA system in male
reproductive tract of rabbit and the relationship between β-NGF and
testosterone levels with seminal quality during sexual maturation.
Theriogenology. 126:206–213. 2019.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Bogetti ME, Pozo Devoto VM, Rapacioli M,
Flores V and Fiszer de Plazas S: NGF, TrkA-P and neuroprotection
after a hypoxic event in the developing central nervous system. Int
J Dev Neurosci. 71:111–121. 2018.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Triaca V, Fico E, Sposato V, Caioli S,
Ciotti MT, Zona C, Mercanti D, La Mendola D, Satriano C, Rizzarelli
E, et al: hNGF peptides elicit the NGF-TrkA signalling pathway in
cholinergic neurons and retain full neurotrophic activity in the
DRG assay. Biomolecules. 10(216)2020.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Zhang L, Peng X, Ai Y, Li L, Zhao S, Liu
Z, Peng Q, Deng S, Huang Y, Mo Y and Huang L: Amitriptyline reduces
sepsis-induced brain damage through TrkA signaling pathway. J Mol
Neurosci. 70:2049–2057. 2020.PubMed/NCBI View Article : Google Scholar
|
